Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Continuing to Structure for Robust and Targeted Growth, PotNetwork Holding, Inc. Appoints Dr. Richard Goulding as New Chief Executive Officer

PotNetwork Holding,Inc
Posted on: 04 Oct 17

PotNetwork Holding, Inc. (OTC Pink:POTN)today announces that as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, the Company has appointed a new Chief Executive Officer, Richard Goulding, MD.

In the Company’s effort to fortify its presence in the industry with a specialized focus, Dr. Goulding is expected to be instrumental in directing the Company’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that studies reveal CBD can help.

Dr. Goulding brings to the Company a knowledge of the medical benefits of CBD from a physician's standpoint. His insight on the latest research utilizing cannabis for pain management and other medical applications is expected to strongly enhance the Company’s ability to excel in this growing sector.

Diamond CBD has purposed to bring together a team of medical professionals with an acquired knowledge of the intricacies CBD’s attributes, and how these components can contribute to the optimization of beneficial results. “This enhancement to our management team is a strategic move to enhance the Company’s capability to contend in a sector of the marketplace focused on the use of CBD for its reportedly wide-scale healing properties and relieving benefits,” stated Maria Gomez, Regional Vice President of Sales of Diamond CBD, Inc.

Dr. Goulding is a Loyola University graduate. He completed his general surgery and Otolaryngology residency at Jackson Memorial Hospital in Miami, Florida. Dr. Goulding was named Chief Resident of Jackson Memorial Hospital in 1983. He later went on to pioneer and establish several industry leading procedures.

“We believe, based on studies and reports, that CBD can contribute impressively to quality of life in those that are able to benefit from its revolutionary attributes,” states Dr. Goulding. He concluded “From what I’ve been able to discover, it seems we have only scratched the surface in this marketplace. It truly is an optimum time to be involved in an industry whose time has come.”

Former CEO, Gary Blum has been appointed as the Company’s new Chairman of the Board, and will continue to serve the Company with his expertise in a more focused capacity. “We are extremely pleased to be experiencing this level of growth, and want to express our gratitude and appreciation to our investors for their continued support as the Company continues to evolve,” stated Gary Blum, Chairman of the Board, PotNetwork Holding, Inc.

PotNetwork has recently formed an advisory board created to provide its subsidiary, Diamond CBD, Inc., with guidance and insight on upcoming formulations. CBD research demonstrates its potential to provide symptomatic relief for a wide range of ailments, including rheumatoid arthritis, diabetes, alcoholism, post traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, among many others. Diamond CBD is focused on continuing this research to develop premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives to potentially address these key markets.

Diamond CBD takes pride in bringing top quality hemp-derived products to market. Whereas these consumables are sold as dietary supplements, the Company makes no claim on the potential effects that their proprietary products will have on anyone's individual illness or symptoms.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171004005522/en/

Business Wire
www.businesswire.com

Last updated on: 04/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.